8% Off
Esmeron50 mg/5 ml
Healthcare Pharmaceuticals Ltd.
৳404.80
Add to cart
Generic medicine
Rocuronium Bromide: Brands, Price & Uses in Bangladesh
Rocuronium Bromide is a non-depolarizing neuromuscular blocking agent (skeletal muscle relaxant) with the following approved use: Established / FDA-approved use Adjunct to general anesthesia —…
About Rocuronium Bromide
Indications of Rocuronium Bromide
Rocuronium Bromide is a non-depolarizing neuromuscular blocking agent (skeletal muscle relaxant) with the following approved use:
Established / FDA-approved use
- Adjunct to general anesthesia — Rocuronium Bromide is used to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or to facilitate mechanical ventilation.
Rocuronium Bromide has no sedative, analgesic, or amnestic effect and must always be given together with adequate general anesthesia or sedation (see Precautions and Warnings). It is intended strictly for use in the operating room, intensive care unit, or other setting equipped for airway management, by personnel experienced in the use of neuromuscular blocking agents.
Dosage & Administration of Rocuronium Bromide
Rocuronium Bromide must be administered only by, or under the direct supervision of, clinicians experienced in the use of neuromuscular blocking agents and in airway management, with facilities for intubation, mechanical ventilation, oxygen therapy, and reversal agents immediately available. Dosing is individualized and ideally guided by peripheral nerve stimulator (train-of-four) monitoring.
| Indication | Population | Typical Dose |
|---|---|---|
| Routine tracheal intubation | Adults | Initial intravenous dose of 0.6 mg/kg (range 0.45–0.6 mg/kg), providing good-to-excellent intubating conditions within about 1–2 minutes. |
| Rapid sequence intubation | Adults | 0.6 to 1.2 mg/kg intravenously, providing intubating conditions in under 2 minutes; higher doses within this range shorten onset further but may prolong duration of blockade. |
| Maintenance of muscle relaxation (intermittent bolus) | Adults | Supplemental doses of 0.1 to 0.2 mg/kg given upon early signs of recovery (e.g., return of twitch response), each providing roughly 12–24 minutes of additional relaxation. |
| Maintenance (continuous infusion) | Adults | Initiated only after early spontaneous recovery from an intubating dose is evident, typically 10–12 mcg/kg/min, then titrated to the desired level of block using neuromuscular monitoring. |
| Routine tracheal intubation / maintenance | Pediatric patients | Initial dose of approximately 0.6 mg/kg (0.45 mg/kg with certain anesthetic techniques); maintenance bolus doses of about 0.15 mg/kg, or infusion at approximately 7–10 mcg/kg/min. Rocuronium Bromide is not recommended for rapid sequence intubation in pediatric patients because safety data for this specific use are insufficient in this age group. |
Hepatic / renal adjustment
In patients with significant hepatic impairment, the duration of action of Rocuronium Bromide may be prolonged; use a conservative dose and monitor neuromuscular function closely. In renal impairment, onset is generally unaffected but duration of action may be modestly prolonged; dose individually with monitoring rather than by fixed adjustment.
Side Effects of Rocuronium Bromide
Common
- Transient hypotension or hypertension (reported in roughly 2% of patients receiving Rocuronium Bromide)
- Tachycardia (reported more frequently in pediatric patients)
Less common
- Injection site reactions (pain, edema) or local irritation with extravasation
- Rash, pruritus
- Bronchospasm, wheezing
- Cardiac arrhythmia
Rare but serious
- Severe anaphylactic/anaphylactoid reactions, some fatal, have been reported with Rocuronium Bromide (see Contraindications and Precautions and Warnings).
- Prolonged or residual neuromuscular blockade with delayed recovery of muscle function and respiration.
- Malignant hyperthermia has been reported very rarely in association with general anesthesia that included Rocuronium Bromide, though animal data have not shown Rocuronium Bromide itself to trigger this reaction.
Contraindications of Rocuronium Bromide
- Known hypersensitivity to Rocuronium Bromide, the bromide ion, or to other non-depolarizing neuromuscular blocking agents (cross-sensitivity/cross-reactivity among neuromuscular blockers, including anaphylaxis, has been reported).
Frequently Asked Questions about Rocuronium Bromide
What is Rocuronium Bromide used for?
Rocuronium Bromide is a muscle-relaxant medicine used only in hospital operating rooms or intensive care units, as part of general anesthesia, to relax the muscles and make it easier to place a breathing tube (tracheal intubation) and to keep muscles relaxed during surgery or while a patient is on a ventilator.
Can Rocuronium Bromide be given to a patient who is awake?
No. Rocuronium Bromide has no effect on consciousness or pain and must always be given together with adequate general anesthesia or sedation, by an anesthesiologist or equally trained clinician, in a setting equipped for breathing support. It is never used as a stand-alone or take-home medicine.
Why does a patient need a breathing tube and ventilator after receiving Rocuronium Bromide?
Rocuronium Bromide temporarily paralyzes the muscles used for breathing along with other skeletal muscles. Because of this, controlled ventilation and airway support are required until the effect wears off or is reversed with medicines such as sugammadex or neostigmine at the end of the procedure.
Is Rocuronium Bromide safe during pregnancy?
Rocuronium Bromide should be used in pregnancy, including during cesarean delivery, only if a physician/anesthesiologist determines that the benefit outweighs the potential risk to the fetus; it is not recommended for rapid sequence induction specifically for cesarean section because of limited safety data in that situation. It is only ever given under direct medical supervision.
What are the main risks of Rocuronium Bromide?
The main risks of Rocuronium Bromide include prolonged muscle paralysis with slow recovery of breathing, low or high blood pressure, and rare but serious allergic (anaphylactic) reactions. These risks are managed by trained anesthesia staff using continuous monitoring and, when needed, reversal medicines.
What happens if too much Rocuronium Bromide is given?
An excessive dose of Rocuronium Bromide can cause prolonged paralysis of the breathing muscles, requiring extended mechanical ventilation. This is managed as a medical emergency in the hospital with continued ventilatory support, sedation, and reversal agents once early recovery is seen; it is not something that occurs or is managed outside a monitored medical setting.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.